At Elevian, we are developing new medicines that promote recovery and regeneration. Our lead program is a recombinant protein for the treatment of stroke in the days following the event, for which there are currently no viable treatments. By promoting regeneration, Elevian’s medicines have the potential to treat and prevent many aging-associated diseases.
Company Details
- Employees
- 6
- Founded
- 2018
- Address
- 90 Bridge St, Newton,massachusetts 02458,united States
- in****@****ian.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- elevian.com
- HQ
- Newton, Massachusetts
Elevian, Inc. Questions
Elevian, Inc.'s website is elevian.com
Elevian, Inc.'s LinkedIn profile is https://www.linkedin.com/company/elevian-inc
Elevian, Inc. has
6 employees.
View email and phone details for 6
employees at Elevian, Inc..
Elevian, Inc.'s industry is
Biotechnology Research
Elevian, Inc.'s top competitors are
Life Biosciences,
Insilico Medicine,
Altos Labs,
Unity Biotechnology,
Calico Life Sciences,
Salubris Biotherapeutics,
Bluerock Therapeutics,
Juvenescence®,
Agex Therapeutics, Inc.,
Alkahest, Inc..
Elevian, Inc.'s support email address is info@elevian.com
Elevian, Inc.'s categories are Biotechnology Research
Elevian, Inc.'s founding year is 2018
